Sulfated glycosaminoglycans support osteoblast functions and concurrently suppress osteoclasts

Journal of Cellular Biochemistry

Volumn 115, Issue 6, 2014, Pages 1101-1111

  Salbach Hirsch, Juliane ^a   Ziegler, Nicole ^a   Thiele, Sylvia ^a   Moeller, Stephanie ^b   Schnabelrauch, Matthias ^b   Hintze, Vera ^c   Scharnweber, Dieter ^c,d   Rauner, Martina ^a   Hofbauer, Lorenz C ^a,d  

^a UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^b BIOMATERIALS DEPARTMENT   (Germany)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

CHONDROITIN SULFATE (CS); GLYCOSAMINOGLYCANS (GAG); HYALURONIC ACID HYALURONAN (HA) SULFATE; OSTEOBLASTS (OB); OSTEOCLASTS (OC)

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; GLYCOSAMINOGLYCAN POLYSULFATE; OSTEOCALCIN; OSTEOPROTEGERIN; A73025; COLLAGEN; GLYCOSAMINOGLYCAN;

ANIMAL CELL; APOPTOSIS; ARTICLE; BONE DEVELOPMENT; BONE REMODELING; CELL ADHESION; CELL DEATH; CELL FUNCTION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; DOWN REGULATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HOMEOSTASIS; LIMIT OF DETECTION; MARKER GENE; MESENCHYMAL STEM CELL; MOLECULAR WEIGHT; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRECURSOR; PRIORITY JOURNAL; SULFATION; ANIMAL; CARBOHYDRATE ANALYSIS; CELL CULTURE; CELL DIFFERENTIATION; CELL LINE; COCULTURE; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION; GENETICS; MESENCHYMAL STROMA CELL; METABOLISM; MOLECULAR GENETICS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TIME;

ALKALINE PHOSPHATASE; ANIMALS; APOPTOSIS; CALCIUM; CARBOHYDRATE SEQUENCE; CELL ADHESION; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; CELLS, CULTURED; COCULTURE TECHNIQUES; COLLAGEN; GENE EXPRESSION; GLYCOSAMINOGLYCANS; MESENCHYMAL STROMAL CELLS; MICE; MOLECULAR SEQUENCE DATA; OSTEOBLASTS; OSTEOCALCIN; OSTEOCLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TIME FACTORS;

EID: 84907421917     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.24750     Document Type: Article

References (41)

1. Atkins GJ, Kostakis P, Pan B, Farrugia A, Gronthos S, Evdokiou A, Harrison K, Findlay DM, Zannettino ACW,. 2003. RANKL expression is related to the differentiation state of human osteoblasts. J Bone Miner Res 18: 1088-1098.
2. Bierbaum S, Douglas T, Hanke T, Scharnweber D, Tippelt S, Monsees TK, Funk RH, Worch H,. 2006. Collageneous matrix coatings on titanium implants modified with decorin and chondroitin sulfate: Characterization and influence on osteoblastic cells. J Biomed Mater Res A 77: 551-562.
3. Bierbaum S, Hintze V, Scharnweber D,. 2012. Functionalization of biomaterial surfaces using artificial extracellular matrices. Biomatter 2: 132-141.
4. Brown SH, Pummill PE,. 2008. Recombinant production of hyaluronic acid. Curr Pharm Biotechnol 9: 239-241.
5. Brydone aS, Meek D, Maclaine S,. 2010. Bone grafting, orthopaedic biomaterials, and the clinical need for bone engineering. P I Mech Eng H 224: 1329-1343.
6. Büttner M, Möller S, Keller M, Huster D, Schiller J, Schnabelrauch M, Dieter P, Hempel U,. 2013. Over-sulfated chondroitin sulfate derivatives induce osteogenic differentiation of hMSC independent of BMP-2 and TGF-β1 signalling. J Cell Physiol 228: 330-340.
7. Chen CC, Boskey AL,. 1985. Mechanisms of proteoglycan inhibition of hydroxyapatite growth. Calcif Tissue Int 37: 395-400.
8. Gower LB,. 2008. Biomimetic model systems for investigating the amorphous precursor pathway and its role in biomineralization. Chem Rev 108: 4551-4627.
9. Haupt LM, Murali S, Mun FK, Teplyuk N, Mei LF, Stein GS, van Wijnen AJ, Nurcombe V, Cool SM,. 2009. The heparan sulfate proteoglycan (HSPG) glypican-3 mediates commitment of MC3T3-E1 cells toward osteogenesis. J Cell Physiol 220: 780-791.
10. Hempel U, Möller S, Noack C, Hintze V, Scharnweber D, Schnabelrauch M, Dieter P,. 2012. Sulfated hyaluronan/collagen I matrices enhance the osteogenic differentiation of human mesenchymal stromal cells in vitro even in the absence of dexamethasone. Acta Biomater Acta Materialia Inc 8: 4064-4072.
11. Hench LL,. 1998. Biomaterials: A forecast for the future. Biomaterials 19: 1419-1423.
12. Hess R, Jaeschke A, Neubert H, Hintze V, Moeller S, Schnabelrauch M, Wiesmann H-P, Hart D a, Scharnweber D,. 2012. Synergistic effect of defined artificial extracellular matrices and pulsed electric fields on osteogenic differentiation of human MSCs. Biomaterials 33: 8975-8985.
13. Hintze V, Miron A, Moeller S, Schnabelrauch M, Wiesmann H-P, Worch H, Scharnweber D,. 2012a. Sulfated hyaluronan and chondroitin sulfate derivatives interact differently with human transforming growth factor-β1 (TGF-β1). Acta Biomater 8: 2144-2152.
14. Hintze V, Miron A, Möller S, Schnabelrauch M, Heinemann S, Worch H, Scharnweber D,. 2012b. Artificial extracellular matrices of collagen and sulphated hyaluronan enhance the differentiation of human mesenchymal stem cells in the presence of dexamethasone. J Tissue Eng Regen Med (Epub ahead of print).
15. Hintze V, Moeller S, Schnabelrauch M, Bierbaum S, Viola M, Worch H, Scharnweber D,. 2009. Modifications of hyaluronan influence the interaction with human bone morphogenetic protein-4 (hBMP-4). Biomacromolecules 10: 3290-3297.
16. Hofbauer LC, Gori F, Riggs BL, Lacey DL, Dunstan CR, Spelsberg TC, Khosla S,. 1999. Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: Potential paracrine mechanisms of glucocorticoid-induced osteoporosis. Endocrinology 140: 4382-4389.
17. Hoshiba T, Kawazoe N, Tateishi T, Chen G,. 2009. Development of stepwise osteogenesis-mimicking matrices for the regulation of mesenchymal stem cell functions. J Biol Chem 284: 31164-31173.
18. Kliemt S, Lange C, Otto W, Hintze V, Möller S, von Bergen M, Hempel U, Kalkhof S,. 2013. Sulfated hyaluronan containing collagen matrices enhance cell-matrix-interaction, endocytosis, and osteogenic differentiation of human mesenchymal stromal cells. J Proteome Res 12: 378-389.
19. Kunze R, Rösler M, Möller S, Schnabelrauch M, Riemer T, Hempel U, Dieter P,. 2010. Sulfated hyaluronan derivatives reduce the proliferation rate of primary rat calvarial osteoblasts. Glycoconj J 27: 151-158.
20. Lamoureux F, Picarda G, Garrigue-Antar L, Baud'huin M, Trichet V, Vidal A, Miot-Noirault E, Pitard B, Heymann D, Rédini F,. 2009. Glycosaminoglycans as potential regulators of osteoprotegerin therapeutic activity in osteosarcoma. Cancer Res 69: 526-536.
21. Livak KJ, Schmittgen TD,. 2001. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25: 402-408.
22. Lutter A-H, Hempel U, Wolf-Brandstetter C, Garbe AI, Goettsch C, Hofbauer LC, Jessberger R, Dieter P,. 2010. A novel resorption assay for osteoclast functionality based on an osteoblast-derived native extracellular matrix. J Cell Biochem 109: 1025-1032.
23. Maeno S, Niki Y, Matsumoto H, Morioka H, Yatabe T, Funayama A, Toyama Y, Taguchi T, Tanaka J,. 2005. The effect of calcium ion concentration on osteoblast viability, proliferation and differentiation in monolayer and 3D culture. Biomaterials 26: 4847-4855.
24. Manton KJ, Leong DFM, Cool SM, Nurcombe V,. 2007. Disruption of heparan and chondroitin sulfate signaling enhances mesenchymal stem cell-derived osteogenic differentiation via bone morphogenetic protein signaling pathways. Stem Cell 25: 2845-2854.
25. Mark MP, Baker JR, Kimata K, Ruch JV,. 1990. Regulated changes in chondroitin sulfation during embryogenesis: An immunohistochemical approach. Int J Dev Biol 34: 191-204.
26. Mathieu LM, Mueller TL, Bourban P-EE, Pioletti DP, Muller R, Manson JA, Müller R, Månson J-AE,. 2006. Architecture and properties of anisotropic polymer composite scaffolds for bone tissue engineering. Biomaterials 27: 905-916.
27. Mucci A,. 2000. 1H and 13C nuclear magnetic resonance identification and characterization of components of chondroitin sulfates of various origin. Carbohyd Polym 21: 37-45.
28. Nagahata M, Tsuchiya T, Ishiguro T, Matsuda N, Nakatsuchi Y, Teramoto A, Hachimori A, Abe K,. 2004. A novel function of N-cadherin and Connexin43: Marked enhancement of alkaline phosphatase activity in rat calvarial osteoblast exposed to sulfated hyaluronan. Biochem Biophys Res Commun 315: 603-611.
29. Pichert A, Samsonov SA, Theisgen S, Thomas L, Baumann L, Schiller J, Beck-Sickinger AG, Huster D, Pisabarro MT,. 2012. Characterization of the interaction of interleukin-8 with hyaluronan, chondroitin sulfate, dermatan sulfate and their sulfated derivatives by spectroscopy and molecular modeling. Glycobiology 22: 134-145.
30. Pittenger MF,. 2008. Mesenchymal stem cells from adult bone marrow. Methods Mol Biol 449: 27-44.
31. Plotkin LI, Bellido T,. 2013. Beyond gap junctions: Connexin43 and bone cell signaling. Bone 52: 157-166.
32. Prince CW, Navia JM,. 1983. Glycosaminoglycan alterations in rat bone due to growth and fluorosis. J Nutr 113: 1576-1582.
33. Rauner M, Sipos W, Goettsch C, Wutzl A, Foisner R, Pietschmann P, Hofbauer LC,. 2009. Inhibition of lamin A/C attenuates osteoblast differentiation and enhances RANKL-dependent osteoclastogenesis. J Bone Miner Res 24: 78-86.
34. Robey PG, Boskey AL,. 2009. The composition of bone. In:, Rosen CJ, editor. Primer on the metabolic bone diseases and disorders of mineral metabolism. Hoboken, NJ, USA: John Wiley & Sons, Inc. pp 32-38.
35. Salbach J, Kliemt S, Rauner M, Rachner TD, Goettsch C, Kalkhof S, von Bergen M, Möller S, Schnabelrauch M, Hintze V, Scharnweber D, Hofbauer LC,. 2012a. The effect of the degree of sulfation of glycosaminoglycans on osteoclast function and signaling pathways. Biomaterials 33: 8418-8429.
36. Salbach J, Rachner TD, Rauner M, Hempel U, Anderegg U, Franz S, Simon J-C, Hofbauer LC,. 2012b. Regenerative potential of glycosaminoglycans for skin and bone. J Mol Med 90: 625-635.
37. Salbach-Hirsch J, Kraemer J, Rauner M, Samsonov SA, Pisabarro MT, Moeller S, Schnabelrauch M, Scharnweber D, Hofbauer LC, Hintze V,. 2013. The promotion of osteoclastogenesis by sulfated hyaluronan through interference with osteoprotegerin and receptor activator of NF-κB ligand/osteoprotegerin complex formation. Biomaterials 34: 7653-7661.
38. Schneider CA, Rasband WS, Eliceiri KW,. 2012. NIH Image to ImageJ: 25 years of image analysis. Nat Methods 9: 671-675.
39. Spector M,. 2013. An interview with I V Yannas. Tracing one of the deepest roots of biomaterials in tissue engineering/regenerative medicine. Biomed Mater 8: 040401.
40. Thomas GP, Baker SU, Eisman JA, Gardiner EM,. 2001. Changing RANKL/OPG mRNA expression in differentiating murine primary osteoblasts. J Endocrinol 170: 451-460.
41. Wojak-Cwik IM, Hintze V, Schnabelrauch M, Moeller S, Dobrzynski P, Pamula E, Scharnweber D,. 2013. Poly(L-lactide-co-glycolide) scaffolds coated with collagen and glycosaminoglycans: Impact on proliferation and osteogenic differentiation of human mesenchymal stem cells. J Biomed Mater Res A 101: 3109-3122.